Mirum Pharmaceuticals Inc... (MIRM)
Mirum Pharmaceuticals Statistics
Share Statistics
Mirum Pharmaceuticals has 49.53M shares outstanding. The number of shares has increased by 3.99% in one year.
| 49.53M |
| 3.99% |
| 2.1% |
| 99.99% |
| n/a |
| 13,827 |
| 3.17% |
Short Selling Information
The latest short interest is 6.29M, so 12.69% of the outstanding shares have been sold short.
| 6.29M |
| 12.69% |
| 12.69% |
| 13.2 |
Valuation Ratios
The PE ratio is -22.34 and the forward PE ratio is -91.08. Mirum Pharmaceuticals's PEG ratio is 0.42.
| -22.34 |
| -91.08 |
| 5.83 |
| 2.4 |
| 8.71 |
| 210.57 |
| 0.42 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Mirum Pharmaceuticals.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 3.1, with a Debt / Equity ratio of 1.41.
| 3.1 |
| 2.93 |
| 1.41 |
| -6.49 |
| 34.05 |
| -6.12 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $1,008,646.71 |
| $-263,299.4 |
| 334 |
| 0.5 |
| 3.64 |
Taxes
| 1.03M |
| -1.19% |
Stock Price Statistics
The stock price has increased by 78.85% in the last 52 weeks. The beta is 0.95, so Mirum Pharmaceuticals's price volatility has been higher than the market average.
| 0.95 |
| 78.85% |
| 42.96 |
| 43.43 |
| 53.25 |
| 436,763 |
Income Statement
In the last 12 months, Mirum Pharmaceuticals had revenue of 336.89M and earned -87.94M in profits. Earnings per share was -1.85.
| 336.89M |
| 255.25M |
| -87.61M |
| -87.94M |
| -48.97M |
| -72.6M |
| -1.85 |
Balance Sheet
The company has 222.5M in cash and 317.76M in debt, giving a net cash position of -95.26M.
| 222.5M |
| 317.76M |
| -95.26M |
| -644.18M |
| 690.25M |
| 283.24M |
Cash Flow
In the last 12 months, operating cash flow was 10.32M and capital expenditures -993K, giving a free cash flow of 9.33M.
| 10.32M |
| -993K |
| 9.33M |
| 0.2 |
Margins
Gross margin is 75.77%, with operating and profit margins of -26% and -26.1%.
| 75.77% |
| -26% |
| -25.8% |
| -26.1% |
| -14.54% |
| -26% |
| 2.77% |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for MIRM is $66, which is 47.8% higher than the current price. The consensus rating is "Buy".
| $66 |
| 47.8% |
| Buy |
| 12 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 2.28 |
| 3 |